JAN 15, 2020 12:38 PM PST

A New Drug Target for Substance Abuse

WRITTEN BY: Nouran Amin

Research carried out by the University of Minnesota Medical School indicates a new drug target for treating a drug addiction. Researchers note that the drug is finding "the hidden stars of the brain." The study was published in Neuron and indicates that targeting the calcium signaling of the star shaped neural supporting cell ‘astrocyte’ could decrease the behavioral effects of drug abuse.

"These findings suggest that astrocytes contribute to amphetamine signaling, dopamine signaling and overall reward signaling in the brain," says Michelle Corkrum said. "Because of this, astrocytes are a potentially novel cell type that can be specifically targeted to develop efficacious therapies for diseases with dysregulated dopamine."

One form of drug abuse comes from amphetamine as a result of dopamine disruption. Dopamine is one of the major molecules in the brain that contribute to learning and memory as well as motivated behaviors. It is believed that when dopamine is disrupted, that is when individuals are more prone to substance abuse, and in that case—amphetamine.

Learn more about substance use disorders:

In the study, astrocytes were found to respond to dopamine when calcium is increased in a region of the brain known as the nucleus accumbens—which is one the major reward centers of the brain. The increase of calcium was correlated with the release of ATP/adenosine to modulate neural activity in the nucleus accumbens.

They also found that amphetamine causes astrocytes to respond when calcium is increased.

"We were able to integrate the phenomenal resources that the U of M offers to conduct state-of-the-art research and work with numerous different core facilities, which played key roles in this study," Corkrum said.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 02, 2020
Drug Discovery & Development
Type 2 Diabetic Drug Combo Proves Effective
NOV 02, 2020
Type 2 Diabetic Drug Combo Proves Effective
A common first-line therapeutic for type 2 diabetes is the metformin drug used to stabilize blood glucose levels. Althou ...
NOV 25, 2020
Immunology
The History of Vaccines
NOV 25, 2020
The History of Vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
NOV 25, 2020
Drug Discovery & Development
Improving Drug Dissolution
NOV 25, 2020
Improving Drug Dissolution
When you take your medicine, it travels through the bloodstream and releases its effects. When the drug dissolves too fa ...
DEC 04, 2020
Drug Discovery & Development
OTC Drug Found Safe for Multiple Myeloma
DEC 04, 2020
OTC Drug Found Safe for Multiple Myeloma
Injecting the immune-boosting drug ‘teclistamab’ was found to be safe and effective in patients with relapse ...
DEC 11, 2020
Drug Discovery & Development
Could Tomatoes Be Therapy for Parkinson?
DEC 11, 2020
Could Tomatoes Be Therapy for Parkinson?
Could tomatoes be the next Parkinson’s drug? Researchers have introduced novel use of tomatoes for therapy. Scient ...
JAN 05, 2021
Neuroscience
Synthetic Psychedelic Treats Depression Without Hallucinations
JAN 05, 2021
Synthetic Psychedelic Treats Depression Without Hallucinations
Psychedelics are receiving an increasing amount of attention- both in research and in the media- for their potential to ...
Loading Comments...